# Catello Somma

> Catello Somma is a Series B investor at TVM Capital Life Science backing Medical and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [TVM Capital Life Science](https://shizune.co/investors/profile/tvm-capital-life-science)
- Location: Munich, Germany
- Total investments: 1
- Last investment: Jun 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://linkedin.com/in/catellosomma
- X (Twitter): https://twitter.com/catello_somma
- Website: https://www.tvm-lifescience.com/

Catello Somma is a Series B investor at TVM Capital Life Science in Munich focused on Medical and Health Care. Catello Somma is the Associate at TVM Capital Life Science. he attended MIP Politecnico di Milano.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Vico Therapeutics | Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands. | $12.3M | Series B | Jun 24, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners) — VC Fund, 2 deals together
- [Ackermans & van Haaren](https://shizune.co/investors/profile/ackermans-van-haaren) — VC Fund, 1 deal together
- [Droia Ventures](https://shizune.co/investors/profile/droia) — VC Fund, 1 deal together
- [Eurazeo](https://shizune.co/investors/profile/eurazeo-com) — VC Fund, 1 deal together
- [EQT Life Sciences](https://shizune.co/investors/profile/life-sciences-partners) — VC Fund, 1 deal together
- [Polaris Partners](https://shizune.co/investors/profile/polaris-partners) — VC Fund, 1 deal together

## About TVM Capital Life Science

VC Fund · Munich, Germany

TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Since inception, TVM Capital Life Science has invested in entrepreneurial venture backed companies. Over several fund generations, their investment strategy has included a multi-stage investment approach spanningdiscovery to market ready companies as well as profitable companies searching for growth capital. Their investment focus has always been broad and includes investments in therapeutics, technology platforms, medtech and diagnostics. They invest in Canada, the U.S., Germany and Western Europe with their dedicated team of investment professionals based in Montreal and Munich.

5 contacts available at TVM Capital Life Science.

| Name | Title | Profile |
| --- | --- | --- |
| Catello Somma | Associate | https://shizune.co/investors/profile/catello-somma |
| Hubert Birner | Managing Partner | https://shizune.co/investors/profile/hubert-birner |
| Luc Marengere | Managing Partner | https://shizune.co/investors/profile/luc-marengere |
| Marc Riviere | General Partner | https://shizune.co/investors/profile/marc-rivi%C3%A8re |
| Sascha Berger | Partner | https://shizune.co/investors/profile/sascha-berger |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Catello Somma invest in?

Catello Somma invests primarily in Medical, Health Care and Pharmaceutical startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Catello Somma last invest?

The most recent investment recorded for Catello Somma closed in Jun 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co